Pharmacological inhibition of pannexin-1 reduces pathophysiological thrombus formation (ISTH 2026) - May 25, 2026 - Abstract #PB2506; Pres time: Jul 13, 2026; 01:45 PM - 02:45 PM; Location: Exhibition Hall- Poster Area; "At intermediate agonist concentrations platelet activation was further reduced by combining spironolactone with aspirin and cangrelor. Panx1 may represent a candidate for the management of CVD. DOI*10.1016/j.rpth.2026.105246"
Hematological Disorders • Inflammation • Thrombosis
|
|
Selen Kurt 1; Tanya Sage 1; Maria Diaz Alonso 1; Neline Kriek 1; Jon Gibbins 1; Kirk Taylor 1
|